10x Genomics Inc. (TXG) News

10x Genomics Inc. (TXG): $22.59

0.36 (-1.57%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add TXG to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#50 of 62

in industry

Filter TXG News Items

TXG News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

TXG News Highlights

  • For TXG, its 30 day story count is now at 6.
  • Over the past 14 days, the trend for TXG's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about TXG are ADD and GENE.

Latest TXG News From Around the Web

Below are the latest news stories about 10X GENOMICS INC that investors may wish to consider to help them evaluate TXG as an investment opportunity.

10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 9:00 a.m. Pacific Time.

Yahoo | December 21, 2023

10x Genomics Launches Xenium Catalyst Network

10x Genomics, Inc., (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of its Xenium Catalyst Network, a global group of technically qualified research institutions that will accelerate access to Xenium proof-of-concept data for researchers worldwide. The four founding members of the Xenium Catalyst Network will add significant capacity for the company's Xenium Catalyst Program, a technical access service launched earlier this year for prospective customers.

Yahoo | December 20, 2023

Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that Nature Communications has published a 10x-conducted study using the Chromium Single Cell, Visium Spatial and Xenium In Situ platforms as part of an integrative approach to understand how tumor microenvironment differences influence invasiveness.

Yahoo | December 19, 2023

Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock

Wood is moving away from fintech and Internet names like COIN stock.

Dana Blankenhorn on InvestorPlace | December 14, 2023

High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking Preprint

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a new non-peer-reviewed study has independently evaluated the technical performance of three spatial imaging platforms and found the Xenium In Situ platform demonstrated higher quality transcript counts per gene at higher specificity for 22 formalin-fixed paraffin-embedded (FFPE) tissues compared to NanoString's CosMx and Vizgen's MERSCOPE. This comparison, presented in a preprint posted to bioRxi

Yahoo | December 13, 2023

12 Best Genomics Stocks To Buy Now

In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there’s one thing that can be said with certainty […]

Yahoo | December 10, 2023

10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a collaboration with the NIH Intramural Center for Alzheimer's and Related Dementias (NIH CARD) to build a more comprehensive single cell atlas of the human brain to further neuroscience research. Known for complementing a broad range of NIH-funded research that requires harnessing emerging technologies at scale, NIH CARD will use Chromium Single Cell Multiome to profile the epigenome and whole transcr

Yahoo | December 7, 2023

Insider Sell Alert: Chief Commercial Officer James Wilbur Sells Shares of 10x Genomics Inc

In the realm of biotechnology, insider transactions often provide valuable insights into the company's financial health and future prospects.

Yahoo | November 23, 2023

Harvard University Stocks List: Top 12 Picks

In this piece, we will take a look at Harvard University stocks list: top 12 picks. If you want to skip our introduction to the institutional investor, then take a look at Harvard University Stocks List: Top 5 Picks. This year turned out to be one of the best years for stocks after a tumultuous 2022 […]

Yahoo | November 19, 2023

10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the District of Delaware has reached a unanimous verdict in favor of 10x Genomics in the patent infringement suit 10x filed against the GeoMx products sold by NanoString Technologies, Inc. (Nasdaq: NSTG). In awarding over $31 million in damages, the jury found that NanoString's GeoMx Digital Spatial Profiler and associated instruments, reagents and services fo

Yahoo | November 17, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!